People who have Hodgkin's lymphoma or systemic anaplastic large cell lymphoma (ALCL) may benefit from chemotherapy treatment with Adcetris. This prescription drug is given through an intravenous (IV) infusion every three weeks, and is only recommended after other chemotherapy treatments have failed. Most people who receive it will develop some type of side effect, such as fatigue, nausea, and diarrhea.
What Is Adcetris?
Adcetris™ (brentuximab vedotin) is a prescription medication approved to treat Hodgkin's lymphoma and a type of non-Hodgkin's lymphoma known as systemic anaplastic large cell lymphoma (ALCL). It is reserved for use after other treatments have failed.
Adcetris is a combination of a drug and an antibody (a protein normally made by the immune system that recognizes and attaches to an antigen). The antibody portion of Adcetris attaches to CD30, an antigen found on the surface of some lymphoma cells. Once attached, Adcetris enters the cell and releases the drug portion. The drug portion of Adcetris binds to tubulin, an important protein found inside the cells, causing the cell to die.
Adcetris was studied in people with Hodgkin's lymphoma and systemic ALCL. In these studies, 73 percent of people with Hodgkin's lymphoma who were given the medication had at least a 50 percent reduction in the size of their lymphoma tumors. In the systemic ALCL studies, 86 percent of people given Adcetris had their tumors shrink by at least half.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click
Would you like to view your HealthSavvy Programs now, or stay on this page and continue reading this article?
In order for us to best serve you and provide you with the best information, can you please tell us if you currently have health insurance?
In order for us to create your customized HealthSavvy programs, we need a little more information about the health topic(s) that you are interested in.
Press "Continue" button below to begin selecting your HealthSavvy topic(s).
Are You Sure?
You've chosen to add topics from the topic group to your selected topics.
Are you sure you want to add all of these topics?
Are You Sure?
You've chosen to clear all of your selected topics. Remember, you need at least one selected topic to use HealthSavvy. If you choose this option, it cannot be undone, and you'll need to choose at least new topic to continue using your HealthSavvy programs.
Are you still sure that you want to clear all of you selected topics?